Clinical Trial Update: Bicalutamide With or Without Metformin for Biochemical Recurrence in Overweight or Obese Prostate Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bicalutamide with or without metformin for biochemical recurrence in overweight/obese prostate cancer patients; study completed with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• bicalutamide (bicalutamide)
• metformin (metformin)

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Cancer of Prostate | Phase 2 | Status: COMPLETED | Results posted: 2022-03-29